Category Archives: DBDS

HomeStanford - Department of Biomedical Data Science  > DBDS
Light bulb in the palm of a hand
Posted on

Data Studio 11/29: Cardiac Events after Radiation of Chemotherapy in Breast Cancer Patients

Cardiac Events after Radiation of Chemotherapy in Breast Cancer Patients

DATE: Wednesday, 29 November 2023

TIME: 3:00–4:30 PM

LOCATION: Conference Room X399, Medical School Office Building, 1265 Welch Road, Stanford, CA

INVESTIGATORS:

Scott Jackson (1)

Michael Binkley (1)

  1. Department of Radiation Oncology

WEBPAGE: https://dbds.stanford.edu/data-studio/

ABSTRACT

The Data Studio Workshop brings together a biomedical investigator with a group of experts for an in-depth session to solicit advice about statistical and study design issues that arise while planning or conducting a research project. This week, the investigator(s) will discuss the following project with the group.

INTRODUCTION

This observational study consists of two patient groups: the treatment group receives combined radiation with Chemotherapy (XRT+Chemo) and the control group receives Chemotherapy (Chemo). Our project concerns competing risk regression for cardiac events. Death is a competing risk. Some of the covariates of interest only apply to the XRT+Chemo patients, namely, those related to radiation.

HYPOTHESIS & AIM

What is the risk for breast cancer patients of cardiac events after either XRT+Chemo or Chemo?

 

For more info:  https://dbds.stanford.edu/data-studio/

Serena Yeung
Posted on

DBDS faculty featured prominently in cover story of latest SOM Magazine: “Medicine’s AI Boom: The Stanford Impact”

Eleven of DBDS’ faculty and associated faculty were featured in the latest issue of Stanford Medicine Magazine.
The Stanford Impact” focused on a wide scope of researchers that impact the AI work done in DBDS, including Nigam Shah, Serena Yeung (pictured), Roxana Daneshjou, Tina Hernandez-Boussard and James Zou.
“If you poll the 1,200 faculty in the School of Medicine, I’d be surprised if more than 10% know about any of Stanford’s AI history,” said Shah, MBBS, PhD, professor of medicine and of biomedical data science and chief data scientist for Stanford Health Care. “A lot of people think this right now is the first AI hype cycle,” the story quoted, and went on to include how AI is defined and in which ways Stanford is taking the lead in the field.
Posted on

Dr. Richard Olshen, pioneer in field of statistics: 1942-2023

Dear DBDS,
It is with deep sorrow that I write to inform you of the passing of Professor Richard Allen Olshen on November 8, 2023.
Professor Olshen will be forever remembered for his pioneering research in the field of statistics and his unyielding passion for academia, especially to our shared mission at Stanford University. Richard played a significant role in advancing statistical learning, notably through his influential work on regression and classification trees. His internationally acclaimed and pioneering work spanned various domains, including gait analysis, digital radiography, and, in more recent years, molecular genetics. As the division chief of Biostatistics in the Department of Health Research and Policy, his leadership, especially in the shaping of biostatistics at Stanford, will be fondly remembered. Professor Olshen was a key figure in the development of the Biostatistics Workshop (predecessor to the weekly department seminar series in DBDS) and Data Studio. His many contributions will leave a lasting imprint on our School of Medicine and Stanford University.
Richard Olshen was born in Portland, Oregon, on May 17, 1942. After completing his undergraduate training at UC Berkeley, he attended Yale University, where he earned his Ph.D. in Statistics in 1966 under the guidance of L.J. Savage. In 1967, he came to Stanford University, marking the beginning of a lifelong connection with our institution. In 1975, Professor Olshen left the Stanford family to join the faculty of the Mathematics Department at UC San Diego. However, his heart remained with Stanford, and he returned in 1989.
Richard Olshen was a passionate mentor to many. In addition to his academic accomplishments, Richard was also a dedicated husband, nurturing father, and doting grandfather. Although we deeply mourn his loss, his influence on our field and the memories of his wisdom and candor will remain as an everlasting tribute. We will provide further information on how to honor his memory with his family once it becomes available. In lieu of flowers, the family prefers donations in honor of his memory to the charity of your choice.
Sincerely,
Sylvia
Posted on

Kevin Wu: Research Talk 11/8

Kevin Wu

Wednesday, November 8th, 2023

2:00 pm – 3:00 pm PST 

CCSR 0235

Zoom Link: https://stanford.zoom.us/j/95984592133?pwd=MDRXcyt4eTlCVlZhdHZYZ0prLzBGZz09

Title: Medical AI After Deployment: Data-driven analyses and methods for clinically viable AI

Abstract: Medical AI algorithms have undergone significant development and regulatory approval, with over 600 FDA-approved medical AI devices currently. However, their actual clinical safety and impact remain unclear. First, we analyze FDA submission documents and find that the majority of FDA approvals do not report multi-site evaluation, and nearly none have prospective analyses. Second, we track the occurrences of newly released AI billing codes in a nationwide insurance claims database and find that only a handful of products have meaningful clinical adoption. Finally, we systematically track device updating in FDA submissions and find that the majority of devices have not had updates to model weights since initial approval. Given these limitations, we propose several methods to address common issues with algorithmic deployment. First, we present a framework for understanding the marginal contribution of distribution shifts to overall model degradation. Second, we present a method for efficient missing data collection in the context of fixed models. Finally, we present ways to improve the robustness of evaluating medical LLMs.

1 … 27 28 29 30 31 … 33